Announced
Completed
Financials
Sources
Tags
biotechnology company
United Kingdom
Biotechnology
Acquisition
Minority
Private Equity
Venture Capital
Friendly
Cross Border
Private
Completed
Synopsis
Nutreco, a provide of animal nutrition and aqua feed, and Olympic Investmentsled a $51m Series B funding round in Enough, a developer of mycoprotein designed to inspire new culinary creations. Additional investors include AXA IM, HAL Investments, Tailored Solutions, CPT Capital and Scottish Enterprise “ENOUGH is an exciting business with real potential to transform protein production. This partnership perfectly supports our ambitions to accelerate the contribution we can make to the challenge of feeding a growing global population. If we are serious about meeting this objective in a sustainable way, we will need to produce protein from a variety of sources such as fermentation, which is very much a shared goal," Rob Koremans, Nutreco CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.